What to do with a patient who has been hallucinating and depressed after being taken off memory medication and is now only taking Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Hallucinations and Depression After Discontinuation of Memory Medication

Immediate Action Required: Urgent Psychiatric Evaluation

This patient requires immediate referral to a mental health professional for comprehensive psychiatric evaluation, as hallucinations combined with depression in a patient with mild cognitive impairment represents a potentially serious neuropsychiatric emergency. 1

Critical Assessment Steps

Determine the Underlying Cause

The hallucinations could stem from multiple etiologies that require different management approaches:

  • Medication withdrawal: Abrupt discontinuation of cholinesterase inhibitors (donepezil, rivastigmine, galantamine) can precipitate neuropsychiatric symptoms including hallucinations and worsening cognition 1

  • Antidepressant-induced hallucinations: Escitalopram (Lexapro) itself can cause hallucinations as a side effect, particularly in patients with cognitive impairment or neurodegenerative conditions 2, 3

  • Underlying delirium: New-onset hallucinations with confusion suggest possible delirium, which requires urgent medical evaluation for infections, metabolic derangements, medication effects, or other acute medical causes 1

  • Charles Bonnet Syndrome: If the patient has any degree of vision impairment, recurrent visual hallucinations with insight that they are not real may represent this benign condition 1

  • Emerging dementia with Lewy bodies or Alzheimer's disease: Hallucinations can be a primary feature of neurodegenerative disease progression 1

Immediate Medical Workup Required

Before psychiatric referral, ensure the following have been evaluated:

  • Vital signs and physical examination looking for signs of infection, dehydration, pain, or acute medical illness 1

  • Medication review: Verify what "memory medication" was discontinued, when it was stopped, and review all current medications for anticholinergic burden or serotonergic effects 1, 2

  • Repeat laboratory studies if not recently done: complete metabolic panel, CBC, thyroid function, B12 level 1

  • Assess for substance withdrawal: Specifically ask about alcohol or benzodiazepine use, as withdrawal can cause hallucinations 1

Referral Decision Algorithm

Refer IMMEDIATELY (same day) if:

  • Patient is threatening harm to self or others 1
  • Severe agitation or inability to care for self 1
  • Lack of insight that hallucinations are not real (suggests psychosis rather than CBS) 1
  • Suicidal ideation 1

Refer URGENTLY (within 1-2 days) if:

  • Hallucinations persist despite addressing medical causes 1
  • Depression is interfering with daily functioning 1
  • No improvement after 30 days of conservative management 1
  • Patient or family cannot safely manage symptoms at home 1

Interim Management While Awaiting Psychiatric Evaluation

Do NOT initiate antipsychotic medications

Antipsychotics should not be prescribed for hypoactive delirium or non-agitated hallucinations in older adults with cognitive impairment due to substantial risks of increased morbidity and mortality. 1 Reserve antipsychotics only for severe agitation threatening substantial harm to self or others 1

Consider Escitalopram Adjustment

  • If hallucinations began AFTER starting escitalopram: Strongly consider discontinuing it, as SSRIs can cause hallucinations particularly in patients with cognitive impairment or when combined with anticholinergic effects 2, 3

  • If hallucinations preceded escitalopram: Continue it for depression treatment, as there is some evidence escitalopram may actually help treat hallucinations in neurodegenerative conditions 4

Avoid Benzodiazepines

Do not prescribe benzodiazepines for hallucinations or depression, as they increase delirium risk, prolong delirium duration, and significantly increase fall risk in older adults. 1 Benzodiazepines are indicated ONLY for alcohol or benzodiazepine withdrawal 1

Consider Restarting Memory Medication

If a cholinesterase inhibitor was abruptly stopped, consider restarting it after psychiatric consultation, as abrupt discontinuation can worsen neuropsychiatric symptoms and the cholinergic deficit may be contributing to hallucinations 2

Non-Pharmacological Interventions

Implement these evidence-based strategies immediately:

  • Environmental modifications: Optimize lighting, reduce noise, maintain familiar surroundings, ensure glasses/hearing aids are used 1

  • Reorientation techniques: Clocks, calendars, familiar objects, consistent caregivers 1

  • Address sensory deficits: Check vision and hearing, as visual impairment increases risk of Charles Bonnet Syndrome 1

  • Family education: Explain that hallucinations may fluctuate, provide reassurance, teach appropriate responses 1

  • Sleep hygiene: Maintain regular sleep-wake cycle, avoid daytime napping 1

Critical Pitfalls to Avoid

  • Do not dismiss hallucinations as "pseudo-hallucinations" or assume they are transient without proper assessment 5, 6

  • Do not combine multiple sedating medications (antipsychotics + benzodiazepines) except in crisis situations, as this dramatically increases fall risk and mortality 1

  • Do not restart memory medication without psychiatric input if hallucinations are severe, as cholinesterase inhibitors can occasionally worsen hallucinations in some patients 1

  • Do not attribute everything to depression - hallucinations in cognitive impairment require thorough evaluation for delirium and neurodegenerative causes 1

Documentation and Communication

Advise the family to:

  • Keep a log of hallucination frequency, content, and timing 1
  • Document any behavioral changes or worsening confusion 1
  • Note any new medications or medical symptoms 1
  • Bring all medications (including over-the-counter) to psychiatric appointment 1

Bottom line: This patient needs urgent psychiatric evaluation within 1-2 days. Do not start antipsychotics or benzodiazepines. Consider whether escitalopram is helping or harming. Focus on safety, medical workup, and non-pharmacological interventions until specialist assessment is complete. 1

Related Questions

What medications can cause hallucinations?
What is the management approach for hallucinations induced by medication treatment, such as those caused by anticholinergic medications or selective serotonin reuptake inhibitors (SSRIs)?
What is the appropriate treatment for a 19-year-old patient with a history of anorexia, long-standing mental health issues since age 12, concerns for bipolar disorder, borderline personality disorder, suicidal ideation (SI) and attempts, presenting with increased depression, suicidal ideation, delusions, and auditory visual hallucinations (AVH) without a prior history of psychosis and not currently on any medications?
What are the considerations for using amitriptyline (tricyclic antidepressant) in patients experiencing hallucinations?
What are the diagnostic criteria and treatment options for psychotic personality traits?
What are the normal reference ranges for thyroid labs in Canada, including Thyroid-Stimulating Hormone (TSH), free T4, and free T3?
What is the best initial management for a baby with regurgitation after meals and other symptoms of Gastroesophageal Reflux Disease (GERD)?
What does a B-type Natriuretic Peptide (BNP) level of 222 translate to in pro-B-type Natriuretic Peptide (pro-BNP)?
What is the recommended neoadjuvant immunotherapy approach for a 57-year-old female with stage 3 submandibular mass and lymph node involvement?
What alternative basal insulin options can be considered for an End-Stage Renal Disease (ESRD) patient on Hemodialysis (HD) 3 times a week, who refuses insulin glargine (Lantus) and has impaired glycemic control?
How should the dose of Lyrica (pregabalin) be increased in patients with increased neuropathy and normal renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.